Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX)

Market Closed
14 Feb, 20:00
NYSE NYSE
$
168. 77
+0.05
+0.03%
After Hours
$
168. 77
0 0%
18.1B Market Cap
20.12 P/E Ratio
3% Div Yield
1,327,100 Volume
8.71 Eps
$ 168.72
Previous Close
Day Range
168.11 171.3
Year Range
123.3 171.3
Earnings results expected in 65 days

Summary

DGX closed today higher at $168.77, an increase of 0.03% from yesterday's close, completing a monthly increase of 11.06% or $16.81. Over the past 12 months, DGX stock gained 11.06%.
DGX pays dividends to its shareholders, with the most recent payment made on Jan 29, 2025. The next announced payment will be in In 2 months on Apr 21, 2025 for a total of $0.8.
The last earnings report, released on Jan 30, 2025, exceeded the consensus estimates by 0.05%. On average, the company has fell short of earnings expectations by -0.75%, based on the last three reports. The next scheduled earnings report is due on Apr 21, 2025.
The stock of the company had never split.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track DGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

DGX Chart

Quest Diagnostics Inc (DGX) FAQ

What is the stock price today?

The current price is $168.77.

On which exchange is it traded?

Quest Diagnostics Inc is listed on NYSE.

What is its stock symbol?

The ticker symbol is DGX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 18.1B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Apr 21, 2025.

Has Quest Diagnostics Inc ever had a stock split?

No, there has never been a stock split.

Quest Diagnostics Inc Profile

Diagnostics & Research Industry
Healthcare Sector
Mr. James E. Davis CEO
NYSE Exchange
US74834L1008 ISIN
United States Country
50,000 Employees
7 Apr 2025 Last Dividend
21 Jun 2005 Last Split
17 Dec 1996 IPO Date

Overview

Quest Diagnostics Incorporated, established in 1967 and based in Secaucus, New Jersey, is a prominent provider of diagnostic testing, information, and services both in the United States and internationally. The company operates with the mission to deliver critical diagnostic insights that lead to informed healthcare decisions. Using its extensive network of laboratories, patient service centers, and healthcare professionals, Quest Diagnostics offers a wide range of diagnostic information services. These services cater to a diverse clientele including physicians, hospitals, patients, health plans, government agencies, employers, and pharmaceutical companies. Through its flagship Quest Diagnostics brand and others such as AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum, the company aims to improve health outcomes by making better information available to the healthcare ecosystem.

Products and Services

  • Diagnostic Information Services
  • These encompass routine and non-routine clinical tests, advanced clinical testing, and anatomic pathology testing. Quest Diagnostics utilizes a vast array of technological platforms to provide critical diagnostic information that supports disease prevention, diagnosis, treatment, and management.

  • Risk Assessment Services for Life Insurance Industry
  • Quest Diagnostics provides comprehensive risk assessment services tailored to the needs of the life insurance sector. These services are designed to help insurance companies evaluate the health risks of policy applicants through a variety of diagnostic tests and assessments.

  • Healthcare Information Technology Solutions
  • Offering cutting-edge information technology solutions, Quest Diagnostics helps healthcare organizations and clinicians enhance efficiency and patient care. These solutions encompass a wide range of IT services designed to facilitate the secure exchange of health information, improve lab ordering processes, and streamline patient record management.

Contact Information

Address: 500 Plaza Drive
Phone: 973 520 2700